Boston Scientific (BSX) ROIC: History & Chart

Name: Boston Scientific Corporation (BSX) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

Boston Scientific Corporation(BSX)

Medical - Devices · Marlborough, MA

$43.93-1.12 (-2.49%)

Delayed quote: Sep 15, 2026, 10:45 AM EDT

Compare

About Boston Scientific Corporation

Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA

59,000 employees

www.bostonscientific.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Michael F. Mahoney

View full financials

BSX Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

10.57%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

8.71%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

6.55%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

5.70%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

5.88%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

4.79%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

3.31%

CURRENT VS TTM AVG

+21.42%

CURRENT VS 3Y AVG

+61.50%

CURRENT VS 5Y AVG

+85.51%

CURRENT VS 10Y AVG

+79.63%

CURRENT VS 15Y AVG

+120.61%

CURRENT VS 20Y AVG

+219.37%

SECTOR MEDIAN · HEALTHCARE

8.75%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+20.88%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
Boston Scientific Corporation (BSX)	$65.30B	10.57%	8.71%	6.55%	5.70%
Cencora, Inc. (COR)vs ›	$62.86B	12.75%	15.09%	14.58%	14.67%
Moderna, Inc. (MRNA)vs ›	$56.82B	-39.16%	-31.38%	-12.74%	0.29%
Cardinal Health, Inc. (CAH)vs ›	$54.75B	13.45%	12.41%	9.39%	5.98%
Cigna Corporation (CI)vs ›	$76.30B	7.69%	7.02%	7.07%	6.51%
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$80.11B	9.19%	9.70%	12.91%	18.41%
Becton, Dickinson and Company (BDX)vs ›	$50.37B	3.72%	4.38%	4.32%	3.88%
Edwards Lifesciences Corporation (EW)vs ›	$49.18B	10.22%	11.08%	14.46%	15.87%
Humana Inc. (HUM)vs ›	$47.79B	4.52%	3.25%	5.37%	7.01%
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$44.72B	6.79%	3.17%	0.33%	-0.73%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

Boston Scientific Corporation (BSX)

$65.30B

10.57%

8.71%

6.55%

5.70%

Cencora, Inc. (COR)vs ›

$62.86B

12.75%

15.09%

14.58%

14.67%

Moderna, Inc. (MRNA)vs ›

$56.82B

-39.16%

-31.38%

-12.74%

0.29%

Cardinal Health, Inc. (CAH)vs ›

$54.75B

13.45%

12.41%

9.39%

5.98%

Cigna Corporation (CI)vs ›

$76.30B

7.69%

7.02%

7.07%

6.51%

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$80.11B

9.19%

9.70%

12.91%

18.41%

Becton, Dickinson and Company (BDX)vs ›

$50.37B

3.72%

4.38%

4.32%

3.88%

Edwards Lifesciences Corporation (EW)vs ›

$49.18B

10.22%

11.08%

14.46%

15.87%

Humana Inc. (HUM)vs ›

$47.79B

4.52%

3.25%

5.37%

7.01%

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$44.72B

6.79%

3.17%

0.33%

-0.73%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Boston Scientific Corporation (BSX)?

The return on invested capital (ROIC) for BSX stock is 10.57%.

Is Boston Scientific Corporation's return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of 10.57% is 86% above its 5-year average of 5.70%, near the high end of its 5-year range (3.93%–10.57%).

What is the TTM average return on invested capital (ROIC) for Boston Scientific Corporation (BSX)?

The TTM average return on invested capital (ROIC) for BSX stock is 8.71%.

What is the 3Y average return on invested capital (ROIC) for Boston Scientific Corporation (BSX)?

The 3Y average return on invested capital (ROIC) for BSX stock is 6.55%.

What is the 5Y average return on invested capital (ROIC) for Boston Scientific Corporation (BSX)?

The 5Y average return on invested capital (ROIC) for BSX stock is 5.70%.

What is the 10Y average return on invested capital (ROIC) for Boston Scientific Corporation (BSX)?

The 10Y average return on invested capital (ROIC) for BSX stock is 5.88%.

What is the 15Y average return on invested capital (ROIC) for Boston Scientific Corporation (BSX)?

The 15Y average return on invested capital (ROIC) for BSX stock is 4.79%.

What is the 20Y average return on invested capital (ROIC) for Boston Scientific Corporation (BSX)?

The 20Y average return on invested capital (ROIC) for BSX stock is 3.31%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-06-30	10.57%
2026-03-31	9.90%
2025-12-31	8.78%
2025-09-30	7.54%
2025-06-30	6.73%
2025-03-31	6.62%
2024-12-31	6.17%
2024-09-30	6.30%
2024-06-30	6.44%
2024-03-31	5.80%
2023-12-31	5.69%
2023-09-30	4.53%
2023-06-30	4.02%
2023-03-31	4.09%
2022-12-31	3.93%
2022-09-30	4.91%
2022-06-30	5.15%
2022-03-31	5.89%
2021-12-31	6.06%
2021-09-30	4.82%
2021-06-30	4.78%
2021-03-31	2.67%
2020-12-31	2.21%
2020-09-30	3.02%
2020-06-30	3.46%
2020-03-31	5.38%
2019-12-31	6.14%
2019-09-30	7.06%
2019-06-30	7.92%
2019-03-31	8.16%
2018-12-31	9.67%
2018-09-30	5.65%
2018-06-30	5.73%
2018-03-31	6.06%
2017-12-31	5.52%
2017-09-30	9.27%
2017-06-30	8.99%
2017-03-31	4.34%
2016-12-31	4.21%
2016-09-30	0.16%
2016-06-30	-4.10%
2016-03-31	-0.38%
2015-12-31	-2.08%
2015-09-30	0.32%
2015-06-30	2.72%
2015-03-31	0.87%
2014-12-31	2.00%
2014-09-30	2.14%
2014-06-30	2.43%
2014-03-31	4.43%
2013-12-31	0.80%
2013-09-30	0.72%
2013-06-30	-4.30%
2013-03-31	-28.30%
2012-12-31	-24.41%
2012-09-30	-24.54%
2012-06-30	-17.72%
2012-03-31	3.98%
2011-12-31	3.03%
2011-09-30	3.93%
2011-06-30	4.27%
2011-03-31	3.99%
2010-12-31	-3.28%
2010-09-30	-10.94%
2010-06-30	-10.63%
2010-03-31	-10.39%
2009-12-31	-2.71%
2009-09-30	-7.57%
2009-06-30	-8.85%
2009-03-31	-8.76%
2008-12-31	-6.30%
2008-09-30	1.83%
2008-06-30	1.13%
2008-03-31	1.04%
2007-12-31	-0.05%
2007-09-30	2.48%
2007-06-30	3.60%
2007-03-31	-11.02%
2006-12-31	-10.36%
2006-09-30	-9.78%
2006-06-30	-11.60%
2006-03-31	8.78%
2005-12-31	9.93%
2005-09-30	9.30%
2005-06-30	17.18%
2005-03-31	21.37%
2004-12-31	16.47%
2004-09-30	13.64%
2004-06-30	12.15%
2004-03-31	11.71%
2003-12-31	10.53%
2003-09-30	10.87%
2003-06-30	12.33%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-06-30

10.57%

2026-03-31

9.90%

2025-12-31

8.78%

2025-09-30

7.54%

2025-06-30

6.73%

2025-03-31

6.62%

2024-12-31

6.17%

2024-09-30

6.30%

2024-06-30

6.44%

2024-03-31

5.80%

2023-12-31

5.69%

2023-09-30

4.53%

2023-06-30

4.02%

2023-03-31

4.09%

2022-12-31

3.93%

2022-09-30

4.91%

2022-06-30

5.15%

2022-03-31

5.89%

2021-12-31

6.06%

2021-09-30

4.82%

2021-06-30

4.78%

2021-03-31

2.67%

2020-12-31

2.21%

2020-09-30

3.02%

2020-06-30

3.46%

2020-03-31

5.38%

2019-12-31

6.14%

2019-09-30

7.06%

2019-06-30

7.92%

2019-03-31

8.16%

2018-12-31

9.67%

2018-09-30

5.65%

2018-06-30

5.73%

2018-03-31

6.06%

2017-12-31

5.52%

2017-09-30

9.27%

2017-06-30

8.99%

2017-03-31

4.34%

2016-12-31

4.21%

2016-09-30

0.16%

2016-06-30

-4.10%

2016-03-31

-0.38%

2015-12-31

-2.08%

2015-09-30

0.32%

2015-06-30

2.72%

2015-03-31

0.87%

2014-12-31

2.00%

2014-09-30

2.14%

2014-06-30

2.43%

2014-03-31

4.43%

2013-12-31

0.80%

2013-09-30

0.72%

2013-06-30

-4.30%

2013-03-31

-28.30%

2012-12-31

-24.41%

2012-09-30

-24.54%

2012-06-30

-17.72%

2012-03-31

3.98%

2011-12-31

3.03%

2011-09-30

3.93%

2011-06-30

4.27%

2011-03-31

3.99%

2010-12-31

-3.28%

2010-09-30

-10.94%

2010-06-30

-10.63%

2010-03-31

-10.39%

2009-12-31

-2.71%

2009-09-30

-7.57%

2009-06-30

-8.85%

2009-03-31

-8.76%

2008-12-31

-6.30%

2008-09-30

1.83%

2008-06-30

1.13%

2008-03-31

1.04%

2007-12-31

-0.05%

2007-09-30

2.48%

2007-06-30

3.60%

2007-03-31

-11.02%

2006-12-31

-10.36%

2006-09-30

-9.78%

2006-06-30

-11.60%

2006-03-31

8.78%

2005-12-31

9.93%

2005-09-30

9.30%

2005-06-30

17.18%

2005-03-31

21.37%

2004-12-31

16.47%

2004-09-30

13.64%

2004-06-30

12.15%

2004-03-31

11.71%

2003-12-31

10.53%

2003-09-30

10.87%

2003-06-30

12.33%

Return on Invested Capital (ROIC): 10.57%

BSX Return on Invested Capital (ROIC)

BSX Average Return on Invested Capital (ROIC) Chart

BSX Current vs Average Return on Invested Capital (ROIC) Chart

BSX Return on Invested Capital (ROIC) Metrics

BSX Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

BSX Return on Invested Capital (ROIC) History

Related Metrics